159 related articles for article (PubMed ID: 15724766)
1. Left ventricular structure and systolic function in African Americans: the Atherosclerosis Risk in Communities (ARIC) study.
Nkomo VT; Arnett DK; Benjamin EJ; Liebson PR; Hutchinson RG; Skelton TN
Ethn Dis; 2004; 14(4):483-8. PubMed ID: 15724766
[TBL] [Abstract][Full Text] [Related]
2. Left ventricular architecture and survival in African-Americans free of coronary heart disease (from the Atherosclerosis Risk in Communities [ARIC] study).
Taylor HA; Penman AD; Han H; Dele-Michael A; Skelton TN; Fox ER; Benjamin EJ; Arnett DK; Mosley TH
Am J Cardiol; 2007 May; 99(10):1413-20. PubMed ID: 17493471
[TBL] [Abstract][Full Text] [Related]
3. Left ventricular mass and systolic dysfunction in essential hypertension.
Schillaci G; Vaudo G; Pasqualini L; Reboldi G; Porcellati C; Verdecchia P
J Hum Hypertens; 2002 Feb; 16(2):117-22. PubMed ID: 11850769
[TBL] [Abstract][Full Text] [Related]
4. Association of Weight and Body Composition on Cardiac Structure and Function in the ARIC Study (Atherosclerosis Risk in Communities).
Bello NA; Cheng S; Claggett B; Shah AM; Ndumele CE; Roca GQ; Santos AB; Gupta D; Vardeny O; Aguilar D; Folsom AR; Butler KR; Kitzman DW; Coresh J; Solomon SD
Circ Heart Fail; 2016 Aug; 9(8):. PubMed ID: 27512104
[TBL] [Abstract][Full Text] [Related]
5. Echocardiographic left ventricular mass in African-Americans: the Jackson cohort of the Atherosclerosis Risk in Communities Study.
Skelton TN; Andrew ME; Arnett DK; Burchfiel CM; Garrison RJ; Samdarshi TE; Taylor HA; Hutchinson RG
Echocardiography; 2003 Feb; 20(2):111-20. PubMed ID: 12848675
[TBL] [Abstract][Full Text] [Related]
6. Effect of electrocardiographic left ventricular hypertrophy on left ventricular systolic function in systemic hypertension (The LIFE Study). Losartan Intervention For Endpoint.
Wachtell K; Rokkedal J; Bella JN; Aalto T; Dahlöf B; Smith G; Roman MJ; Ibsen H; Aurigemma GP; Devereux RB
Am J Cardiol; 2001 Jan; 87(1):54-60. PubMed ID: 11137834
[TBL] [Abstract][Full Text] [Related]
7. Relations of diastolic left ventricular filling to systolic chamber and myocardial contractility in hypertensive patients with left ventricular hypertrophy (The PRESERVE Study).
Palmieri V; Bella JN; DeQuattro V; Roman MJ; Hahn RT; Dahlof B; Sharpe N; Lau CP; Chen WC; Paran E; de Simone G; Devereux RB
Am J Cardiol; 1999 Sep; 84(5):558-62. PubMed ID: 10482155
[TBL] [Abstract][Full Text] [Related]
8. Association of African Ancestry With Electrocardiographic Voltage and Concentric Left Ventricular Hypertrophy: The Dallas Heart Study.
Alame AJ; Garg S; Kozlitina J; Ayers C; Peshock RM; Matulevicius SA; Drazner MH
JAMA Cardiol; 2018 Dec; 3(12):1167-1173. PubMed ID: 30427995
[TBL] [Abstract][Full Text] [Related]
9. Left ventricular wall stresses and wall stress-mass-heart rate products in hypertensive patients with electrocardiographic left ventricular hypertrophy: the LIFE study. Losartan Intervention For Endpoint reduction in hypertension.
Devereux RB; Roman MJ; Palmieri V; Okin PM; Boman K; Gerdts E; Nieminen MS; Papademetriou V; Wachtell K; Dahlöf B
J Hypertens; 2000 Aug; 18(8):1129-38. PubMed ID: 10954006
[TBL] [Abstract][Full Text] [Related]
10. Comparison of the prognostic value of left ventricular hypertrophy in African-American men versus women.
Nunez E; Arnett DK; Benjamin EJ; Oakes JM; Liebson PR; Skelton TN
Am J Cardiol; 2004 Dec; 94(11):1383-90. PubMed ID: 15566908
[TBL] [Abstract][Full Text] [Related]
11. Echocardiographic left ventricular mass index predicts incident stroke in African Americans: Atherosclerosis Risk in Communities (ARIC) Study.
Fox ER; Alnabhan N; Penman AD; Butler KR; Taylor HA; Skelton TN; Mosley TH
Stroke; 2007 Oct; 38(10):2686-91. PubMed ID: 17761924
[TBL] [Abstract][Full Text] [Related]
12. Combined Circumferential and Longitudinal Left Ventricular Systolic Dysfunction in Patients with Rheumatoid Arthritis without Overt Cardiac Disease.
Cioffi G; Viapiana O; Ognibeni F; Dalbeni A; Gatti D; Mazzone C; Faganello G; Di Lenarda A; Adami S; Rossini M
J Am Soc Echocardiogr; 2016 Jul; 29(7):689-98. PubMed ID: 26922258
[TBL] [Abstract][Full Text] [Related]
13. Changes in midwall systolic performance and cardiac hypertrophy reduction in hypertensive patients.
Muiesan ML; Salvetti M; Monteduro C; Rizzoni D; Corbellini C; Castellano M; Porteri E; Agabiti-Rosei E
J Hypertens; 2000 Nov; 18(11):1651-6. PubMed ID: 11081779
[TBL] [Abstract][Full Text] [Related]
14. Effect of regression of left ventricular hypertrophy from systemic hypertension on systolic function assessed by midwall shortening (HOT echocardiographic study).
Zabalgoitia M; Rahman SN; Haley WE; Yarows S; Krause L; Anderson LC; Oraby MA; Amarena J
Am J Cardiol; 2001 Sep; 88(5):521-5. PubMed ID: 11524061
[TBL] [Abstract][Full Text] [Related]
15. Relation of impaired left ventricular filling to systolic midwall mechanics in hypertensive patients with normal left ventricular systolic chamber function: the Losartan Intervention for Endpoint Reduction in Hypertension (LIFE) study.
Wachtell K; Papademetriou V; Smith G; Gerdts E; Dahlöf B; Engblom E; Aurigemma GP; Bella JN; Ibsen H; Rokkedal J; Devereux RB
Am Heart J; 2004 Sep; 148(3):538-44. PubMed ID: 15389245
[TBL] [Abstract][Full Text] [Related]
16. Gender differences in systolic left ventricular function in hypertensive patients with electrocardiographic left ventricular hypertrophy (the LIFE study).
Gerdts E; Zabalgoitia M; Björnstad H; Svendsen TL; Devereux RB
Am J Cardiol; 2001 Apr; 87(8):980-3; A4. PubMed ID: 11305990
[TBL] [Abstract][Full Text] [Related]
17. Urine albumin/creatinine ratio and echocardiographic left ventricular structure and function in hypertensive patients with electrocardiographic left ventricular hypertrophy: the LIFE study. Losartan Intervention for Endpoint Reduction.
Wachtell K; Palmieri V; Olsen MH; Bella JN; Aalto T; Dahlöf B; Gerdts E; Wright JT; Papademetriou V; Mogensen CE; Borch-Johnsen K; Ibsen H; Devereux RB
Am Heart J; 2002 Feb; 143(2):319-26. PubMed ID: 11835038
[TBL] [Abstract][Full Text] [Related]
18. Race-ethnic and sex differences in left ventricular structure and function: the Coronary Artery Risk Development in Young Adults (CARDIA) Study.
Kishi S; Reis JP; Venkatesh BA; Gidding SS; Armstrong AC; Jacobs DR; Sidney S; Wu CO; Cook NL; Lewis CE; Schreiner PJ; Isogawa A; Liu K; Lima JA
J Am Heart Assoc; 2015 Mar; 4(3):e001264. PubMed ID: 25770024
[TBL] [Abstract][Full Text] [Related]
19. Left ventricular midwall mechanics in subjects with aortic stenosis and normal systolic chamber function.
Ballo P; Mondillo S; Motto A; Faraguti SA
J Heart Valve Dis; 2006 Sep; 15(5):639-50. PubMed ID: 17044369
[TBL] [Abstract][Full Text] [Related]
20. Relationship of cardiovascular risk factors to echocardiographic left ventricular mass in healthy young black and white adult men and women. The CARDIA study. Coronary Artery Risk Development in Young Adults.
Gardin JM; Wagenknecht LE; Anton-Culver H; Flack J; Gidding S; Kurosaki T; Wong ND; Manolio TA
Circulation; 1995 Aug; 92(3):380-7. PubMed ID: 7634452
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
